撤稿声明: Targeting KDM4A-AS1 represses AR/AR-Vs deubiquitination and enhances enzalutamide response in CRPC (Retraction of Vol 41, Pg 387, 2022)-MedSci.cn

撤稿声明: Targeting KDM4A-AS1 represses AR/AR-Vs deubiquitination and enhances enzalutamide response in CRPC (Retraction of Vol 41, Pg 387, 2022)

Zhang, BY; Zhang, MP; Yang, YJ; Li, Q; Yu, JP; Zhu, SM; Niu, YJ; Shang, ZQ

Shang, ZQ (通讯作者)，Tianjin Med Univ, Hosp 2, Tianjin Inst Urol, Tianjin 300211, Peoples R China.

ONCOGENE, 2023; 42 (36): 2711

科室
- - 订阅+
  - 更多科室
工具
服务